In recent years there has been renewed interest in the use of dextran, not as a plasma expander, but in the treatment of thrombophlebitis and arterial insufhciency. We would like to report our experience of 7 cases of anaphylaxis in 40 patients treated with dextran; molecular weight 75,000 ± 15,000.1 Three of these reactions were related to dextran supplied by one drug company and the others connected with dextran from another company. We have found in reviewing the literature that this incidence of 17 per cent is much higher than ever previously reported after administration of dextran. 2-10 Several extensive studies of the clinical use of this polysaccharide have revealed a very low incidence of any type of allergic reactions.Although dextran, a polysaccharide product of the fermentation of sucrose by the organism Leuconostoc mesenteroides, has long been known to be allergenic in humans, the incidence of adverse reactions has been very low. Dextran was first used in the United States in 1953 in the control of shock from war wounds and has been widely used since without many major problems.We treated 40 patients with either thrombophlebitis or inoperable peripheral arterial insufficiency with dextran. The following examples are illustrative case reports of four patients out of the seven who developed anaphylaxis while receiving this therapy; no other drugs were being administered at the time of the reaction. CASE REPORTSM. B., a 34-year-old white woman, developed pain, tenderness and swelling in the left lower leg 30 days after surgery for a herniated lumbar disc. There was marked tenderness in the calf of the left leg. Homan's sign was positive. She was diagnosed as having thrombophlebitis of her lower left leg. She was adequately anticoagulated with sodium warfarin, but had persistent swelling, calf and femoral tenderness and positive Homan's sign. Dextran, 6 per cent, was started. After 30 drops at 5 to 7 drops per min., she had the prodromal symptoms of diffuse tingling, hot flushed sensation and later respiratory difficulty. She became cyanotic, with periods of apnea and gasping respirations.Pulse and blood pressure were unobtainable, and the heart sounds were barely audible. The dextran was stopped and the patient was treated with adrenalin, vasopressors and corticosteroids. After 4 hr., she was improved and had an uneventful hospital course.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.